Concepedia

Granulocyte–macrophage colony-stimulating factor (GM-CSF) priming with successive concomitant low-dose Ara-C for elderly patients with secondary/refractory acute myeloid leukemia or advanced myelodysplastic syndrome

H A Rossi, Joanne A. O’Donnell, F Sarcinelli, FM Stewart, PJ Quesenberry, PS Becker

Leukemia · 2002 · 20 citations · 33 references

DOI

Concepts

References

33

International Scoring System for Evaluating Prognosis in Myelodysplastic Syndromes

Peter L. Greenberg, Christopher Cox, Michelle M. LeBeau et al. · Blood · 1997 · 4.5K citations · Full text

, , +13

Multidrug resistance (mdr1) gene expression in adult acute leukemias: correlations with treatment outcome and in vitro drug sensitivity

JP Marie, R Zittoun, BI Sikic · Blood · 1991 · 396 citations · Full text

, , +17

Low-dose cytarabine versus intensive chemotherapy in the treatment of acute nonlymphocytic leukemia in the elderly.

Hervé Tilly, Sylvie Castaigné, Dominique Bordessoule et al. · Journal of Clinical Oncology · 1990 · 258 citations

, , +17

Use of recombinant GM-CSF during and after remission induction chemotherapy in patients aged 61 years and older with acute myeloid leukemia: final report of AML-11, a phase III randomized study of the Leukemia Cooperative Group of European Organisation for the Research and Treatment of Cancer and the Dutch Belgian Hemato-Oncology Cooperative Group.

Bob Löwenberg, Stefan Suciu, E Archimbaud et al. · PubMed · 1997 · 206 citations

, , +17

Randomized Phase II Study of Fludarabine + Cytosine Arabinoside + Idarubicin ± All-Trans Retinoic Acid ± Granulocyte Colony-Stimulating Factor in Poor Prognosis Newly Diagnosed Acute Myeloid Leukemia and Myelodysplastic Syndrome

Elihu H. Estey, Peter F. Thall, Sherry Pierce et al. · Blood · 1999 · 203 citations

, , +16